Introduction
In the 2016 edition of WHO classification, MRI has included on the front page making it vital for the final integrated diagnosis of gliomas. So far, At least seven molecular markers are established with their counter imaging features bringing revolution in the diagnosis and management of brain tumors.
The major markers are IDH,1p19q, ATRX, BRAF, MGMT, H3K27 and RELA. This review provides a very overview of molecular markers and imaging relevance. f. H3K27 mutation: H3K27 mutant status and clinically aggressive course cannot be ruled out based on low grade histology on the initial biopsy, exophytic growth only focal or minimal enhancement or an extra pontine location such as mid brain or medulla. These results favor an integrated approach employing a combination of clinical, radiologic, histologic features as well as H3K27 immuno hisyoxjemistry for the diagnostic subclassification of adult brain stem gliomas [6] .
Review of Evidence
g. RELA: Mostly supratentorial ependymoma are RELA positive [7] .
Conclusion
This review provides a very brief overview linking molecular markers and imaging and provides insight for more research and establishment of criterions.
